• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Myocardial Infarction (1969); Occlusion (1984); Cardiogenic Shock (2262); Stenosis (2263); Reaction (2414)
Event Date 12/28/2016
Event Type  Injury  
Manufacturer Narrative
Literature review: doi: 10.1016/j.Carrev.2016.12.020.
 
Event Description
One cocr zotarolimus-eluting stent (zes) was implanted in the proximal to mid rca to treat the restenosis.Four overlapped cocr zes were also implanted from the mid lad to left main to treat restenosis.Six months later, patient presented with severe restenosis at both vessels.Due to recurrent and aggressive restenosis, metal allergy was suspected.The patient revealed previous contact dermatitis and a specific test confirmed nickle allergy.After the finding, pci with paclitaxel eluting balloons was performed with good final result.Six months later, a cardiac tomography scan revealed severe anterior ischemia.Coronary angiography revealed critical restenosis at ostial lad, and severe restenosis at mid lad with an occluded distal vessel.The rca presented a moderate restenosis at mid and distal segment.Coronary artery bypass grafting (cabg) was performed with a left internal mammary artery (lima) to cx and with saphenous vein graft (svg) to the posterolateral branch of the rca.Two months later, the patient presented a non st elevation myocardial infarction complicated with cardiogenic shock.An emergent ca showed an occlusive restenosis of ostial lad and proximal rca and a critical stenosis of the ostial cx, svg was occluded.Pci was carried out using bioresorbable vascular scaffold (bvs) at lm-cx and a prescription of prednisolone daily.After six months, patient remains asymptomatic.Angiographic follow-up showed neither restenosis nor thrombosis of bvs and improvement of collateral circulation to rca and lad.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7114871
MDR Text Key94786135
Report Number9612164-2017-01925
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-